Liudi Tang

711 total citations
15 papers, 567 citations indexed

About

Liudi Tang is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Liudi Tang has authored 15 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Hepatology and 5 papers in Immunology. Recurrent topics in Liudi Tang's work include Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (8 papers) and interferon and immune responses (5 papers). Liudi Tang is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (8 papers) and interferon and immune responses (5 papers). Liudi Tang collaborates with scholars based in United States and China. Liudi Tang's co-authors include Ju‐Tao Guo, Jinhong Chang, Junjun Cheng, Muhammad Sheraz, Qiong Zhao, Mohit Sehgal, Tianlun Zhou, Bowei Liu, Yan Zhou and John L. Kulp and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Liudi Tang

15 papers receiving 562 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Liudi Tang	326	245	204	187	155	15	567
Daniela Stadler	309 0.9×	212 0.9×	194 1.0×	159 0.9×	111 0.7×	14	516
Kaitao Zhao	398 1.2×	238 1.0×	261 1.3×	83 0.4×	130 0.8×	38	628
Abdul Ghafoor Khan	271 0.8×	273 1.1×	315 1.5×	194 1.0×	104 0.7×	15	748
Chunkyu Ko	561 1.7×	398 1.6×	261 1.3×	92 0.5×	140 0.9×	27	758
Fabien Abdul	386 1.2×	225 0.9×	252 1.2×	78 0.4×	126 0.8×	10	590
L. Earnest-Silveira	540 1.7×	515 2.1×	122 0.6×	79 0.4×	116 0.7×	19	719
Philipp Schult	147 0.5×	133 0.5×	197 1.0×	78 0.4×	71 0.5×	13	457
Bidisha Mitra	380 1.2×	275 1.1×	107 0.5×	100 0.5×	81 0.5×	15	467
Qiong Zhao	398 1.2×	296 1.2×	122 0.6×	69 0.4×	91 0.6×	23	533
Karel A. van Dort	262 0.8×	187 0.8×	216 1.1×	288 1.5×	106 0.7×	31	719

Countries citing papers authored by Liudi Tang

Since Specialization

Citations

This map shows the geographic impact of Liudi Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liudi Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liudi Tang more than expected).

Fields of papers citing papers by Liudi Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liudi Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liudi Tang. The network helps show where Liudi Tang may publish in the future.

Co-authorship network of co-authors of Liudi Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Liudi Tang. A scholar is included among the top collaborators of Liudi Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liudi Tang. Liudi Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Li, You, Stanley M. Lemon, Jason A. Clement, et al.. (2024). “PROTAC” modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro. Bioorganic & Medicinal Chemistry Letters. 102. 129680–129680. 9 indexed citations

Tang, Liudi, et al.. (2024). An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity. Antiviral Research. 226. 105888–105888. 5 indexed citations

Remiszewski, Stacy, Matthew J. Todd, John L. Kulp, et al.. (2023). An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity. Journal of Clinical Investigation. 133(12). 14 indexed citations

Zhao, Qiong, Hui Liu, Liudi Tang, et al.. (2023). Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy. Antiviral Research. 221. 105782–105782. 32 indexed citations

Tang, Liudi, Ping An, Qiong Zhao, et al.. (2022). Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA. Journal of Virology. 97(1). e0126122–e0126122. 3 indexed citations

Hu, Jin, Liudi Tang, Junjun Cheng, et al.. (2021). Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases. Emerging Microbes & Infections. 10(1). 852–864. 23 indexed citations

Cheng, Junjun, Qiong Zhao, Yan Zhou, et al.. (2020). Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription. Journal of Virology. 94(17). 25 indexed citations

Zhang, Xiaohui, Bowei Liu, Liudi Tang, et al.. (2019). Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist. ACS Infectious Diseases. 5(7). 1139–1149. 54 indexed citations

Tang, Liudi, et al.. (2019). DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA. PLoS Pathogens. 15(4). e1007742–e1007742. 67 indexed citations

10.

Sheraz, Muhammad, Junjun Cheng, Liudi Tang, Jinhong Chang, & Ju‐Tao Guo. (2019). Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA. Journal of Virology. 93(11). 61 indexed citations

11.

Hu, Jin, Junjun Cheng, Liudi Tang, et al.. (2018). Virological Basis for the Cure of Chronic Hepatitis B. ACS Infectious Diseases. 5(5). 659–674. 44 indexed citations

12.

Pang, Bo, Nan Wu, Rongwei Guan, et al.. (2017). Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial–Mesenchymal Transition. Clinical Cancer Research. 23(18). 5598–5610. 60 indexed citations

13.

Liu, Bowei, Liudi Tang, Xiaohui Zhang, et al.. (2017). A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists. Antiviral Research. 147. 37–46. 61 indexed citations

14.

Guo, Fang, Liudi Tang, Sainan Shu, et al.. (2017). Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 61(10). 66 indexed citations

15.

Tang, Liudi, Qiong Zhao, Shuo Wu, et al.. (2016). The current status and future directions of hepatitis B antiviral drug discovery. Expert Opinion on Drug Discovery. 12(1). 5–15. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact